—
C+
C+ The full Closelook — membership. Open the C+ overview

Roivant Sciences Ltd (ROIV) — Quality & forensics

As of 2026-09-22 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

37 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

40.97 Altman Z-Score

Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

1/8 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

Continue: the ROIV chart & overview · the earnings record

FAQ · from the current data · as of 2026-09-22

Quick answers

What is Roivant Sciences Ltd's Closelook quality reading?

The composite reads 37/100 across 7 modules, as of 2026-09-22: valuation 37, quality 20, growth 1, balance sheet 97, cash quality 1, capital allocation 45, momentum 82. Closelook scores are research diary readings, not ratings or investment advice.

What is Roivant Sciences Ltd's Altman Z-Score?

40.97, which sits in the safe zone (above 2.99) as of 2026-09-22. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Roivant Sciences Ltd's Piotroski F-Score?

1 of 8, as of 2026-09-22. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.